PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of brmedjLink to Publisher's site
 
Br Med J. 1974 March 9; 1(5905): 409–412.
PMCID: PMC1633257

Menopausal Flushing: Double-blind Trial of a Non-hormonal Medication

Abstract

A multicentre, placebo-controlled, double-blind, cross-over study conducted in general practice on 100 patients has shown clonidine to have a statistically highly significant effect in controlling the number and the severity and duration of menopausal flushes. The relatively mild side effects and the absence of potentially harmful oestrogenic effects suggest that clonidine in the dose range 25 to 75 μg twice daily is a useful addition or alternative to the existing therapy for this common symptom of the menopause.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (780K), or click on a page image below to browse page by page.

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group